Michael Gertner

Michael Gertner, PhD, serves as the VP Senior Medical Director at Biolumina since September 2023, following a tenure as Senior Scientific Director at Fishawack Health from November 2020 to September 2023, where responsibilities included overseeing medical strategy and regulatory compliance in hematology/oncology. Gertner’s previous roles encompass Medical Director at Syneos Health Communications, where strategic marketing for immuno-oncology campaigns was directed, and various medical writing and consulting positions across renowned health organizations and educational institutions. With a PhD in Neuroscience from Albert Einstein College of Medicine, Gertner has significant experience in scientific research and healthcare consulting, contributing to substantial revenue growth, successful therapy launches, and marketing strategies in complex therapeutic areas.